1.22% 0.0055

cbdMD Inc (YCBD)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

cbdMD Inc Stock (YCBD) Company Profile

Healthcare (1064)

704-445-5800

4521 Sharon Road, Charlotte, NC

Nächster Verdiensttermin

Neueste SEC-Einreichungen

YCBD's Discussions on Twitter

Compare YCBD vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
YCBD cbdMD Inc	0.456	5.24M	19.98M	-2.66M	-2.65M	-0.4087
TAK Takeda Pharmaceutical Co Adr	17.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.53	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.80	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	69.69	29.36B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.70	20.39B	3.17B	1.29B	1.01B	27.09

cbdMD Inc Aktie (YCBD) Neueste Nachrichten

Finanzdaten der cbdMD Inc-Aktie (YCBD)

cbdMD Inc (YCBD)

cbdMD Inc Stock (YCBD) Company Profile

Compare YCBD vs TAK, TEVA, HLN, ZTS, UTHR

cbdMD Inc Aktie (YCBD) Neueste Nachrichten

cbdMD, Inc. Share Price Live Today – AMEX:YCBD Stock Price, Chart, News, History - Upstox

What Does cbdMD, Inc.'s (YCBD) Latest Move Mean for Cannabis Stocks Investors? - kalkinemedia.com

Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation - PR Newswire

Why Is cbdMD (NYSE American:YCBD) Buying Twinlab Brand Assets? - kalkinemedia.com

Cbdmd Stock Price Forecast. Should You Buy YCBD? - StockInvest.us

cbdMD to buy Twinlab as supplement M&A heats up - SupplySide Supplement Journal

YCBD Q2 2026 Earnings: Deep Loss Miss Raises Questions as Shares Fall 3.76%Revenue Growth Outlook - vinanet.vn

cbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11) - scanx.trade

Twinlab Assets Acquired by cbdMD Amid Creditor Assignment - The Globe and Mail

cbdMD to Acquire Twinlab's Legacy Supplement Brands - Nutritional Outlook

cbdMD to Acquire Twinlab Brands, Expanding Consumer Wellness Portfolio - citybiz

CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. - marketscreener.com

cbdMD acquires legacy supplement brand Twinlab - NutraIngredients.com

cbdMD’s Acquisition of Supplement Legacy Brand Twinlab Creates Unique Synergy - WholeFoods Magazine

cbdMD agrees to acquire Twinlab brands - Chain Drug Review

Twinlab Sets Asset Sale to cbdMD for $3.98 Million; Consideration Goes to Akretive - TradingView

cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com Nigeria

cbdMD to acquire Twinlab brands, boosting reven... - Pluang

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire

cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView

CbdMDto Assume $1.75 Mln Debt as Part of D - Moomoo

YCBD Q2 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines 2.0%Share Dilution Risk - dars.gov.et

YCBD | cbdMD, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative

cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingAnalyst Drop Coverage - siam.in

cbdMD Inc (YCBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

cbdMD Inc (YCBD) Stock News Today - TradingKey

Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5 - Moomoo

YCBD Downgraded by Maxim Group -- Rating Changed to Hold - GuruFocus

Maxim Group Downgrades cbdMD to Hold From Buy - marketscreener.com

Conferencia de resultados del T3 fiscal de 2026 de CBDMD (YCBD): los ingresos aumentan un 20%, objetivo de reducción de costos - TradingKey

YCBD|cbdMD Inc|Price:0.470|Chg%:-0.005 - TradingKey

cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance

YCBD Q3 FY2026 earnings call - finance.biggo.com

cbdMD Q3 2026 Earnings Call: Complete Transcript - Benzinga

Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours - Investing.com

Transcript : CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 - marketscreener.com

cbdMD Q3 FY2026 Earnings: Revenue Grows 20% as Gross Margin Narrows - TradingKey

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - PR Newswire

cbdMD, Inc. (NYSE: YCBD) grows sales to $16.2M amid going concern warning - Stock Titan

cbdMD (NYSE American:YCBD): What Does the Latest Update Mean for Brand Demand? - Kalkine Media

cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

cbdMD schedules conference call on quarterly results - Bitget

cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results - Yahoo Finance

cbdMD Inc. (YCBD) Holds Steady at $0.58 as Traders Eye Key $0.55–$0.61 RangeWave Truncation - dars.gov.et

CBD Gummy Bears Stock SymbolView gF7h08LSE - Diario AS

Senate bill proposes delay of hemp product restrictions By Investing.com - Investing.com UK

cbdMD Inc. (YCBD) Surges 12% to $0.57: Key Levels to WatchChart Pattern Alerts - dars.gov.et

cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - TradingView

Cbdmd Cbd Oil Tincture Review: What Customers Are Saying Fall 2026 [WY2QyUdh5WG] - Diario AS

YCBD|cbdMD Inc|Price:0.507|Chg%:+0.034 - TradingKey

Finanzdaten der cbdMD Inc-Aktie (YCBD)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie YCBD